Platelet BioGenesis logo — Pioneering the future of medicine with breakthrough technolo...

Platelet BioGenesis

Pioneering the future of medicine with breakthrough technology for producing donor-independent human platelets from stem cells

Founded 2014 Series B Total: $132.10M Biotechnology, Life Sciences

General Information

Company Name Platelet BioGenesis
Founded Year 2014
Industries Biotechnology, Life Sciences
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Platelet BioGenesis. To contact Platelet BioGenesis, visit plateletbiogenesis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Platelet BioGenesis compare?

A PDF of Platelet BioGenesis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Platelet BioGenesis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Platelet BioGenesis

Platelet BioGenesis, founded in 2014, is a biotechnology startup pioneering the future of medicine with breakthrough technology for producing donor-independent human platelets from stem cells. Specializing in biotechnology, platelets, and drug discovery, the company has developed a unique approach to generate donor-independent human platelets from human induced pluripotent stem cells. In November 2021, the company secured a significant $75.50M Series B investment. The investors contributing to this round include Qiming Venture Partners, K2 HealthVentures, Symbiosis LLC, Ziff Capital Partners, Oxford Finance LLC. Platelet BioGenesis is contributing to advancements in biotechnology and life sciences with its innovative approach to platelet production.

Business keywords: platelets, drug discovery, therapeutics, stem cells, donor-independent, induced pluripotent stem cells

Funding Rounds & Investors (14)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $75.50M 5
Qiming Venture Partners, K2 HealthVentures +3
04 Nov 2021
Grant $2.30M 1
Medical Technology Enterprise Consortium
16 Dec 2019
Series A $26.00M 4
eCoast Angels, Qiming Venture Partners +2
09 Sep 2019
Series A $11.36M -
05 Jun 2019
Series A Undisclosed 1
EQx Fund
31 May 2019
Grant $3.50M 1
U.S. Department of Defense
28 Jun 2018
Grant $200.00K 1
Massachusetts Life Sciences Center
28 Jun 2017
Series A $10.00M 5
Qiming Venture Partners, Vivo Capital +3
08 Jun 2017
Grant $600.00K 1
National Institute of Allergy and Infectious Diseases
14 Jan 2017
Debt Financing $1.13M -
28 Jul 2016

View All 14 Funding Rounds

Platelet BioGenesis Alternatives & Competitors

View All Alternatives
Platelet BioGenesis vs

Pioneering medical treatment using advanced stem cell technology to address critical cardiovascular...

Venture round
Biotechnology, Life Sciences
Platelet BioGenesis vs

Medicines to keep you biologically young by targeting the pathological cells that drive chronic dise...

Series A
32 employees
Biotechnology, Health Care
Platelet BioGenesis vs
MICA Biosystems
MICA Biosystems United Kingdom

An innovative and dynamic biotech start-up, unlocking the potential of stem cells and nanotechnology...

Grant
9 employees
Biotechnology, Health Care

FAQ About Platelet BioGenesis

Pioneering the future of medicine with breakthrough technology for producing donor-independent human platelets from stem cells
Platelet BioGenesis was founded in 2014.
Platelet BioGenesis operates in Biotechnology and Life Sciences. Its work centres on platelets, drug discovery, therapeutics and stem cells.
Platelet BioGenesis has completed 14 funding rounds, raising a total of $132.10M. The latest funding stage is Series B.
Top alternatives and competitors to Platelet BioGenesis include Khloris Biosciences, Rubedo Life Sciences, MICA Biosystems, Vicinitas Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Platelet BioGenesis and Khloris Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Platelet BioGenesis, https://bouncewatch.com/company/platelet-biogenesis, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes